Atara Biotherapeutics (ATRA) Other Operating Expenses (2013 - 2026)

Atara Biotherapeutics' Other Operating Expenses history runs 9 years deep, the most recent figure standing at $124000.0 for Q1 2026.

• Quarterly Other Operating Expenses fell 99.39% year-over-year to $124000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $897000.0 (down 97.73% YoY) and the FY2025 annual result came in at $21.2 million, up 0.97% from the prior year.
• Other Operating Expenses was $124000.0 for Q1 2026 at Atara Biotherapeutics, up from $104000.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $50.2 million in Q2 2022 and bottomed at $104000.0 in Q4 2025.
• A 5-year average of $8.4 million and a median of $2.0 million in 2024 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2025 — Other Operating Expenses surged 929.67% — and 2026, when it slumped 99.39%.
• Atara Biotherapeutics' Other Operating Expenses stood at $50.2 million in 2022, then slumped by 99.57% to $216000.0 in 2023, then jumped by 3045.83% to $6.8 million in 2024, then sank by 98.47% to $104000.0 in 2025, then rose by 19.23% to $124000.0 in 2026.
• Business Quant data shows ATRA's Other Operating Expenses at $124000.0 in Q1 2026, $104000.0 in Q4 2025, and $115000.0 in Q3 2025.